A new strategy has been developed to curb Covid-19, in which funding for health care and public health measures in the amount of 254,269,517 euros is provided, according to the Covid-19 strategy of Prime Minister Krišjānis Kariņš (JV) reviewed at the government meeting on Tuesday.
–
The aim of the new strategy is to effectively manage the epidemiological risks and situation in the country, to improve the management of the health system and to provide health care to all patients and, as far as possible, without reducing the volume of services. At the same time, it is planned not to possibly affect the availability and quality of health care services, observing the epidemiological safety requirements in the conditions of limited infrastructure and available human resources.
The largest amount of money, or a total of 65,949,951 euros, is intended to strengthen the laboratory service during an emergency situation. It is planned that this would provide Covid-19 testing for 8,000 people and maintenance for 1,500 people.
The second largest item in the amount of EUR 52,603,500 is the provision of personal protective equipment for the following year. Thus, it is planned to provide the entire treatment process with personal protective equipment.
Meanwhile, it is planned to allocate 50,200,147 euros for changes in the infrastructure of medical institutions, including reconstruction, construction of new buildings and annexes, separation of patient flows. These funds would be used to improve the infrastructure of medical institutions in accordance with epidemiological safety measures, ensuring the availability of health care services, including during emergencies, and separating patient flows. Funding is also provided for the creation of new departments.
In turn, it is planned to allocate 25,220,227 euros for changes in the organization of health care, including the availability of health care services. At the same time, a total of 16,740,586 euros is planned for the recalculation of service payment tariffs and the provision of safety standards in the treatment process.
Among other measures, an effective logistics scheme for Covid-19 vaccines is planned for € 190,194, with a further € 90,000 to improve and ensure the flow of information between laboratories, the Center for Disease Prevention and Control, the Health Inspectorate and GPs about new Covid-19 vaccines. cases.
A deadline of two months is set for the improvement of the circulation of the above-mentioned information, as well as for the registration and registration of the contact persons of the electronic tool Covid-19. In turn, it is planned to allocate 60,000 euros for the registration and registration of contact persons.
At the same time, it is planned to improve the system for attracting additional specialists for epidemiological surveillance work in a crisis situation. The aim is to ensure that one specialist works with no more than ten cases a day.
The € 45,000 is also intended to identify public attitudes and behavioral patterns, including mobility, following the introduction or reduction of epidemiological security measures. In turn, for 60,000 euros, it is planned to conduct regular public information campaigns to change public attitudes and behavior.
The new strategy provides, inter alia, for an additional EUR 13 325 268 to cover the procurement of Covid-19 vaccines in line with the introduction of Covid-19 vaccines in the European Union. Thus, it is planned to provide vaccination against Covid-19 to at least 950,000 Latvian residents.
It is also planned to create an optimal network of vaccination institutions for 15,500,270 euros, including off-site vaccination services to ensure the availability of vaccines to the public. For 60,000 euros, it is planned to implement a campaign to inform the public about the importance of vaccination against Covid-19 and the safety of vaccines.
The strategy envisages the creation of drug reserves for hospitals for the next year for 8,308,895 euros. Allocating these funds to the establishment of a three-month drug reserve would ensure the continuity of the treatment process, the strategy explains.
At the same time, the strategy outlines the tasks to be performed. Among them, it is planned to improve the methodology of introduction and abolition of epidemiological safety measures in accordance with the latest scientific evidence and examples of good practice, as well as to optimize the efficiency of epidemiological surveillance.
It is also planned to ensure the continuity of the activities of the institutions involved in epidemiological surveillance, as well as to promote public participation in the implementation of Covid-19 restrictive measures. At the same time, it is planned to monitor the vaccination process of Covid-19, including monitoring the efficacy and safety of vaccines, including raising public awareness of the importance and involvement of vaccination.
The strategy was developed on the basis of a resolution issued by the Prime Minister on 12 November this year.
– .
